These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 24573690)

  • 1. Hypoxia promotes stem-like properties of laryngeal cancer cell lines by increasing the CD133+ stem cell fraction.
    Wu CP; Du HD; Gong HL; Li DW; Tao L; Tian J; Zhou L
    Int J Oncol; 2014 May; 44(5):1652-60. PubMed ID: 24573690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia promotes radioresistance of CD133-positive Hep-2 human laryngeal squamous carcinoma cells in vitro.
    Wang M; Li X; Qu Y; Xu O; Sun Q
    Int J Oncol; 2013 Jul; 43(1):131-40. PubMed ID: 23652853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo investigation of CD133 as a putative marker of cancer stem cells in Hep-2 cell line.
    Wei XD; Zhou L; Cheng L; Tian J; Jiang JJ; Maccallum J
    Head Neck; 2009 Jan; 31(1):94-101. PubMed ID: 18853445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoresistance of CD133+ cancer stem cells in laryngeal carcinoma.
    Yang JP; Liu Y; Zhong W; Yu D; Wen LJ; Jin CS
    Chin Med J (Engl); 2011 Apr; 124(7):1055-60. PubMed ID: 21542968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer.
    Horst D; Scheel SK; Liebmann S; Neumann J; Maatz S; Kirchner T; Jung A
    J Pathol; 2009 Dec; 219(4):427-34. PubMed ID: 19621338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bmi-1 is essential for the oncogenic potential in CD133(+) human laryngeal cancer cells.
    Wei X; He J; Wang J; Yang X; Ma B
    Tumour Biol; 2015 Nov; 36(11):8931-42. PubMed ID: 26081615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha.
    Soeda A; Park M; Lee D; Mintz A; Androutsellis-Theotokis A; McKay RD; Engh J; Iwama T; Kunisada T; Kassam AB; Pollack IF; Park DM
    Oncogene; 2009 Nov; 28(45):3949-59. PubMed ID: 19718046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia induces tumor aggressiveness and the expansion of CD133-positive cells in a hypoxia-inducible factor-1α-dependent manner in pancreatic cancer cells.
    Hashimoto O; Shimizu K; Semba S; Chiba S; Ku Y; Yokozaki H; Hori Y
    Pathobiology; 2011; 78(4):181-92. PubMed ID: 21778785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experimental investigation of CD133 as a putative marker of tumor-initiating cell in laryngeal carcinoma].
    Wei XD; Zhou L; Cheng L; Tian J
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2006 Dec; 41(12):940-4. PubMed ID: 17345710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia increases gefitinib-resistant lung cancer stem cells through the activation of insulin-like growth factor 1 receptor.
    Murakami A; Takahashi F; Nurwidya F; Kobayashi I; Minakata K; Hashimoto M; Nara T; Kato M; Tajima K; Shimada N; Iwakami S; Moriyama M; Moriyama H; Koizumi F; Takahashi K
    PLoS One; 2014; 9(1):e86459. PubMed ID: 24489728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional repression of cancer stem cell marker CD133 by tumor suppressor p53.
    Park EK; Lee JC; Park JW; Bang SY; Yi SA; Kim BK; Park JH; Kwon SH; You JS; Nam SW; Cho EJ; Han JW
    Cell Death Dis; 2015 Nov; 6(11):e1964. PubMed ID: 26539911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hypoxic microenvironment upgrades stem-like properties of ovarian cancer cells.
    Liang D; Ma Y; Liu J; Trope CG; Holm R; Nesland JM; Suo Z
    BMC Cancer; 2012 May; 12():201. PubMed ID: 22642602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of autophagy by hypoxia-inducible factor-1α promotes EMT and metastatic ability of CD133+ pancreatic cancer stem-like cells during intermittent hypoxia.
    Zhu H; Wang D; Zhang L; Xie X; Wu Y; Liu Y; Shao G; Su Z
    Oncol Rep; 2014 Sep; 32(3):935-42. PubMed ID: 24994549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD133 silencing inhibits stemness properties and enhances chemoradiosensitivity in CD133-positive liver cancer stem cells.
    Lan X; Wu YZ; Wang Y; Wu FR; Zang CB; Tang C; Cao S; Li SL
    Int J Mol Med; 2013 Feb; 31(2):315-24. PubMed ID: 23233126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of cancer stem cells from human glioblastomas: growth and differentiation capabilities and CD133/prominin-1 expression.
    Gambelli F; Sasdelli F; Manini I; Gambarana C; Oliveri G; Miracco C; Sorrentino V
    Cell Biol Int; 2012 Jan; 36(1):29-38. PubMed ID: 21916848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD133, one of the markers of cancer stem cells in Hep-2 cell line.
    Zhou L; Wei X; Cheng L; Tian J; Jiang JJ
    Laryngoscope; 2007 Mar; 117(3):455-60. PubMed ID: 17334305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of CD133 in synovial sarcoma.
    Terry J; Nielsen T
    Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):159-65. PubMed ID: 19752721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD133 is a marker of bioenergetic stress in human glioma.
    Griguer CE; Oliva CR; Gobin E; Marcorelles P; Benos DJ; Lancaster JR; Gillespie GY
    PLoS One; 2008; 3(11):e3655. PubMed ID: 18985161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Copper-64-diacetyl-bis (N4-methylthiosemicarbazone) accumulates in rich regions of CD133+ highly tumorigenic cells in mouse colon carcinoma.
    Yoshii Y; Furukawa T; Kiyono Y; Watanabe R; Waki A; Mori T; Yoshii H; Oh M; Asai T; Okazawa H; Welch MJ; Fujibayashi Y
    Nucl Med Biol; 2010 May; 37(4):395-404. PubMed ID: 20447549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-Transcriptome Analysis of CD133+CD144+ Cancer Stem Cells Derived from Human Laryngeal Squamous Cell Carcinoma Cells.
    Wu Y; Zhang Y; Niu M; Shi Y; Liu H; Yang D; Li F; Lu Y; Bo Y; Zhang R; Li Z; Luo H; Cui J; Sang J; Xiang C; Gao W; Wen S
    Cell Physiol Biochem; 2018; 47(4):1696-1710. PubMed ID: 29949786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.